Marinomed Biotech AG | WebDisclosure

Basculer en Français

10606	Companies
225089	Keywords
153794	Articles
119111	Press releases

Home
Companies
Marinomed Biotech AG

PRESS RELEASE

published on 03/19/2026 at 16:14, 3 months 2 days ago

EQS-Adhoc: Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approximately EUR 2 million
Marinomed Biotech AG announces cash capital increase of EUR 2 million to cover short-term capital needs. Existing shareholders will have subscription rights. Goal is to generate at least EUR 2 million in gross proceeds

Cash Capital Increase Marinomed Biotech AG Subscription Rights EUR 2 Million Short-term Capital Requirements
BRIEF

published on 10/06/2025 at 15:01, 8 months 15 days ago

Marinomed Biotech AG explore des alternatives stratégiques pour la plateforme Marinosolv

Marinomed Biotech Innovation Biotechnologique Plateforme Marinosolv Options Stratégiques Partenariats En Santé
BRIEF

published on 10/06/2025 at 15:01, 8 months 15 days ago

Marinomed Biotech AG Explores Strategic Alternatives for Marinosolv Platform

Strategic Options Marinomed Biotech Biotech Innovation Marinosolv Platform Health Partnerships
PRESS RELEASE

published on 10/06/2025 at 14:56, 8 months 15 days ago

EQS-Adhoc: Marinomed Biotech AG begins reviewing strategic options for the Marinosolv platform
Marinomed Biotech AG initiates strategic review of Marinosolv platform following successful capital measures. Evaluation may include partnerships for Budesolv and Tacrosolv projects

Strategic Partnerships Marinomed Biotech AG Strategic Review Marinosolv Platform Capital Measures
BRIEF

published on 10/01/2025 at 12:23, 8 months 20 days ago

Marinomed Biotech AG : First Berlin Equity réitère sa recommandation d'achat

Résultats Financiers Augmentation De Capital Marinomed Biotech AG Recommandation D'achat Accords De Licence
BRIEF

published on 10/01/2025 at 12:23, 8 months 20 days ago

Marinomed Biotech AG: First Berlin Equity Reiterates Buy Rating

Financial Results Buy Recommendation Capital Increase Marinomed Biotech AG Licensing Deals
PRESS RELEASE

published on 10/01/2025 at 12:18, 8 months 20 days ago

Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirmed a Buy rating and EUR 50.00 price target for Marinomed Biotech AG. H1 results were in line with expectations, with nearly tripled sales and positive AEBITDA amid strategic financial moves

First Berlin Equity Research BUY Rating Marinomed Biotech AG H1 Results EUR 50.00 Price Target
BRIEF

published on 09/17/2025 at 13:53, 9 months 4 days ago

Marinomed Biotech AG Reports Significant Growth in H1 2025

Financial Results Revenue Increase EBIT Growth Capital Measures Biotech Growth
BRIEF

published on 09/17/2025 at 13:53, 9 months 4 days ago

Marinomed Biotech AG annonce une croissance significative au premier semestre 2025

Résultats Financiers Augmentation Des Revenus Croissance Du Résultat D'exploitation (EBIT) Croissance De La Biotechnologie Mesures De Capital
PRESS RELEASE

published on 09/17/2025 at 13:48, 9 months 4 days ago

Marinomed Biotech AG announces results for the first half year of 2025
Marinomed Biotech AG reports strong financial results for the first half of 2025, with revenues of EUR 7.2 million and EBIT of EUR 21.0 million. The company secured financing through capital measures

Revenues Financial Results EBIT Marinomed Biotech AG Capital Measures

Accesswire

Published on 06/22/2026 at 09:01, 1 hour ago

Apex Drills 14.9 m of 5.09 % REO and 12.3 m of 5.63 % REO with > 2.50 % REO Intercept Over 191.9 m in the Trinity Zone at the Rift Rare Earth Project
Published on 06/22/2026 at 03:00, 7 hours 1 minute ago

Tunkillia Pre-Feasibility Study Begins
Published on 06/20/2026 at 01:00, 2 days 9 hours ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 10 hours ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 3 days 5 hours ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp

View all ACCESSWIRE

EQS Group

Published on 06/22/2026 at 09:32, 29 minutes ago

cyan AG adds FileWave as a new partner for cyan Guard 360
Published on 06/22/2026 at 09:06, 55 minutes ago

Sirma Becomes Temenos Referral Partner
Published on 06/22/2026 at 09:05, 55 minutes ago

Intersolar 2026: Jackery Celebrates the Global Debut of Jackery Ark AI EMS and Unveils a Solar Lounge for the Garden
Published on 06/22/2026 at 09:05, 55 minutes ago

OUKITEL Unveils Next-Gen EP2500 Balcony Energy Storage System at Intersolar Europe 2026
Published on 06/22/2026 at 09:00, 1 hour 1 minute ago

Official list Notice

Les Echos

Published on 06/22/2026 at 08:30, 1 hour 31 minutes ago

Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne
Published on 06/22/2026 at 08:30, 1 hour 31 minutes ago

Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 14 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 14 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 14 hours ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026

View all LES ECHOS COMFI WIRE